Aesthetic Connect PCL
Aesthetic Connect PCL provides pharmaceutical products and services, primarily generating revenue through the sale of medical and aesthetic treatments.
Business. Aesthetic Connect PCL (TRPM.BK) is a healthcare services and equipment company headquartered in Thailand, primarily engaged in pharmaceutical activities within the healthcare facilities and services industry. The firm operates on a service-revenue model and is listed on the Stock Exchange of Thailand (SET). Specific details regarding operating segments and geographic revenue mix are not disclosed.
Analyst recommendations
1 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Aesthetic Connect PCL (TRPM.BK) is a healthcare services and equipment company headquartered in Thailand, primarily engaged in pharmaceutical activities within the healthcare facilities and services industry. The firm operates on a service-revenue model and is listed on the Stock Exchange of Thailand (SET). Specific details regarding operating segments and geographic revenue mix are not disclosed.
Aesthetic Connect PCL maintains a strong capital structure with a debt-to-equity ratio of 0.01, indicating minimal leverage and a conservative financing approach. The company's liquidity position is characterized by a current ratio of 13.71, suggesting robust short-term liquidity. However, the company reports negative net cash of -8.14 million THB, which raises concerns about its immediate liquidity position.
In terms of profitability, the company's return on equity (ROE) is 2.5%, and its return on assets (ROA) is 2.36%, both of which are below the industry median for Healthcare Facilities & Services. This suggests that the company is underperforming relative to its peers in terms of capital efficiency and asset utilization.
The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of diversification may expose the company to higher operational and market risks.
Looking ahead, the company's growth trajectory is expected to remain stable, with no significant revenue growth projected in the next fiscal year. The company's capital expenditure of -30.09 million THB indicates a net outflow, which may be used for expansion or asset replacement.
The company faces moderate liquidity risk due to its negative net cash position, which could limit its ability to fund operations without external financing. The risk assessment also notes a low dilution potential, suggesting that the company is unlikely to issue additional shares in the near term.
Recent filings and transcripts do not indicate any material events or strategic shifts that would significantly impact the company's operations or financial performance. The company's financial statements remain consistent with prior periods, with no major anomalies reported.
- Aesthetic Connect PCL maintains a conservative capital structure with minimal leverage.
- The company's profitability metrics are below industry medians, indicating underperformance.
- The company's liquidity position is mixed, with a strong current ratio but negative net cash.
- Growth is expected to remain stable, with no significant revenue expansion projected.
- The company is unlikely to face near-term dilution pressure.
Bull / Bear case
Generated · model-assistedDebt-to-equity ratio of 0.01 is well below the 0.32 cohort median, reflecting a conservative capital structure with minimal leverage risk.
Revenue grew at a 7.3% CAGR over four years, showing consistent top-line expansion despite recent annual volatility.
The single analyst consensus rating is a buy with a target price of 5.05 THB, suggesting potential upside.
Cash conversion ratio of 0.65 is below the 1.35 cohort median, suggesting weaker ability to convert earnings into cash.
In focus — financials by report
Revenue THB 471.7M, −11,6% YoY; Operating income −35,9% YoY.
- ▍Revenue THB 471.7M, −11,6% YoY
- ▍Operating income −35,9% YoY
- ▍Net income −37,4% YoY
- ▍Free cash flow +21,7% YoY
- ▍Net margin 18.5%
Revenue THB 533.7M, −24,6% YoY; Operating income −30,9% YoY.
- ▍Revenue THB 533.7M, −24,6% YoY
- ▍Operating income −30,9% YoY
- ▍Net income −27,6% YoY
- ▍Free cash flow −45,9% YoY
- ▍Net margin 26.1%
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 0,30 |
| Revenue | —no estimate | —no estimate | 514,0M THB |
| Operating income | —no estimate | —no estimate | —no estimate |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Aesthetic Connect PCL Market data — financials · 2026-05-29
- Aesthetic Connect PCL Market data — analyst estimates · 2026-05-29